Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Joshua Trbovich

Physician Assistant Washington, PA Physician Assistant

NPI 1861761504 CMS profile 11173441

380 W Chestnut St Ste 101, Washington, PA 15301

Open in the dashboard

General payments

$144,204

922 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joshua Trbovich of Washington, PA is reported in the CMS Open Payments database as having received $144,204 across 922 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $36,161 208
2024 General $30,082 217
2023 General $27,777 196
2022 General $31,415 187
2021 General $18,769 114

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joshua Trbovich
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Joshua Trbovich were reported at $36,161. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Joshua Trbovich Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $18,769 $132 $37–$438 $132
2022 $31,415 $155 $48–$522 $149
2023 $27,777 $167 $52–$557 $160
2024 $30,082 $178 $55–$600 $164
2025 $36,161 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. SI-BONE, Inc. $128,574 661 payments
  2. Abbott Laboratories $11,889 214 payments
  3. RTI Surgical, Inc. $2,125 7 payments
  4. Smith+Nephew, Inc. $434 4 payments
  5. Cerapedics, Inc. $385 15 payments
  6. Stryker Corporation $240 7 payments
  7. Medtronic, Inc. $160 1 payment
  8. VB Spine LLC $124 5 payments
  9. Boston Scientific Corporation $84 2 payments
  10. Baxter Healthcare $71 3 payments
  11. Other $116 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $85,573 155 payments
  2. Travel and Lodging $35,133 318 payments
  3. Food and Beverage $23,435 448 payments
  4. Education $63 1 payment
Products named General payments · program years 2021–2025
  1. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $57,816 258 payments
  2. IFUSE IMPLANT $41,093 220 payments
  3. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $23,112 117 payments
  4. PROCLAIM Neuromodulation $3,104 64 payments
  5. COFLEX INTERLAMINAR TECHNOLOGY, 10MM $2,080 5 payments
  6. ETERNA $1,768 23 payments
  7. PROCLAIM Neuromodulation $1,136 13 payments
  8. Proclaim IPG $1,128 14 payments
  9. PENTA Structural Heart $814 22 payments
  10. PENTA Neuromodulation $806 36 payments
  11. Other $4,697 81 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

239

Median for Physician Assistant: 241

Drug cost

$2,209

Median for Physician Assistant: $4,110

Branded share of claims

6.7%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methocarbamol Generic 53 $582
Etodolac Generic 17 $419
Diclofenac Sodium Generic 42 $379
Gabapentin Generic 22 $268
Oxycodone Hcl Generic 48 $258
Methylprednisolone Generic 14 $126
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 16 $94
Meloxicam Generic 27 $83

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 16 billing codes

Paid by Medicare

$7,009

Medicare's payments for the services billed

Medicare patients

68

Average age 74

Services billed

89

37 women, 31 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 32%
Diabetes 31%
Depression 28%
Chronic kidney disease 26%
Osteoporosis 25%
Atrial fibrillation 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

922 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record